Monocacy Therapeutics

Private

Frederick, MarylandHealthcare & Life Scienceshttps://monocacytx.com

Last Round

Grant

Jul 2, 2026

Total Funding Raised

$5,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Monocacy Therapeutics is a biotechnology company developing first-in-class immune medicines guided by artificial intelligence to restore optimal immune function and health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Application

Keywords

AI drug discoveryimmunotherapytechbiodrug discovery platformcomputational biologyimmuno-oncologyautoimmune disease therapyin silico drug discoverypreclinical biotechnologyfirst-in-class therapiesmedical AIprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Monocacy Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Monocacy Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Monocacy Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jul 2, 2026
Seed Round	May 27, 2026

View all Funding Rounds

Monocacy Therapeutics Investors

Notable investors and investment history

Monocacy Therapeutics investors
Investor	Rounds
TEDCO	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 27, 2026
$114K round completed

View all signals

Monocacy Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Monocacy Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Monocacy Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersFrederick, Maryland

Year FoundedN/A

Last FundingJul 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.